Related Experiment Video
Updated: Aug 16, 2026
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell
1Section of Cancer Genetics and Microarray Core Facility, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
To identify the molecular changes that occur in non-small cell lung carcinoma (NSCLC), we compared the gene expression profile of the NCI-H292 (H292) NSCLC cell line with that of normal human tracheobronchial epithelial (NHTBE) cells. The NHTBE cells were grown in a three-dimensional organotypic culture system that permits maintenance of the normal pseudostratified mucociliary phenotype characteristic of bronchial epithelium in vivo. Microarray analysis using the Affymetrix oligonucleotide chip U95Av2 revealed that 1,683 genes showed a >1.5-fold change in expression in the H292 cell line relative to the NHTBE cells. Specifically, 418 genes were downregulated and 1,265 were upregulated in the H292 cells. The expression data for selected genes were validated in several different NSCLC cell lines using quantitative real-time PCR and Western analysis. Further analysis of the differentially expressed genes indicated that WNT responses, apoptosis, cell cycle regulation and cell proliferation were significantly altered in the H292 cells. Functional analysis using fluorescence-activated cell sorting confirmed concurrent changes in the activity of these pathways in the H292 line. These findings show that (1) NSCLC cells display deregulation of the WNT, apoptosis, proliferation and cell cycle pathways, as has been found in many other types of cancer cells, and (2) that organotypically cultured NHTBE cells can be used as a reference to identify genes and pathways that are differentially expressed in tumor cells derived from bronchogenic epithelium.
Insights
This study compared gene expression in non-small cell lung carcinoma (NSCLC) cells to normal bronchial cells, revealing significant alterations in WNT, apoptosis, cell cycle, and proliferation pathways crucial for cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Gene Expression Analysis
Background:
- Non-small cell lung carcinoma (NSCLC) molecular landscape requires detailed understanding.
- Normal human tracheobronchial epithelial (NHTBE) cells offer a baseline for comparison.
- Organotypic culture systems preserve in vivo bronchial epithelial characteristics.
Purpose of the Study:
- To identify molecular and gene expression differences between NSCLC and normal bronchial cells.
- To characterize alterations in key cellular pathways within NSCLC.
- To validate NHTBE cells as a reliable reference model.
Main Methods:
- Gene expression profiling using Affymetrix U95Av2 microarrays.
- Quantitative real-time PCR and Western blot analysis for validation.
- Functional pathway analysis via fluorescence-activated cell sorting.
Main Results:
- 1,683 genes exhibited >1.5-fold expression change in H292 NSCLC cells versus NHTBE cells.
- 418 genes were downregulated; 1,265 genes were upregulated in H292 cells.
- Significant alterations observed in WNT response, apoptosis, cell cycle, and proliferation pathways.
Conclusions:
- NSCLC cells exhibit deregulation of WNT, apoptosis, proliferation, and cell cycle pathways.
- Organotypically cultured NHTBE cells serve as an effective reference for identifying differential gene expression in lung tumors.
